NexCAR 19 cancer therapy: Conceived at IIT Bombay, delivered in Tata Memorial : vimarsana.com

CAR T-cell therapy involves modifying a patient’s T-cells—white blood cells that are integral to the immune system. The lab-modified cells are then infused in the patient to multiply and fight cancerous cells. The therapy costs $400,000 in the US and tenth of that in India. But, does it work?

Related Keywords

Mirzapur , Uttar Pradesh , India , Madrid , Spain , Bombay , Maharashtra , Mumbai , Germany , Faridabad , Haryana , United States , Lucknow , American , Americans , Alka Dwivedi , Sanjay Verghese , Hasmukh Jain , Rahul Purwar , Atharva Karulkar , Medizinische Hochschule Hannover , Gaurav Narula , University Of Colorado Anschutz , Gates Institute , Tata Memorial Centre , Hannover Medical School , National Institutes Of Health , Harvard Medical School , Society For Innovation , Central Drugs Standard Control Organisation , Lucknow University , National Cancer Institute , Indian Institute Of Technology , Amrita Hospital , View Full Image , Indian Institute , Tata Memorial Hospital , Stanford Medicine , Hail Mary , Her Phd , National Institutes , Tata Memorial , Terry Fry , Colorado Anschutz , B Cell Leukaemia , Iit Bombay , Nexcar 19 , Immunoact , Society For Innovation And Entrepreneurship , Cancer , Chemotherapy , B Cell ,